Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

Beijing Cancer Hospital, Beijing

Harbin Meidical University Cancer Hospital, Harbin

Tianjin Medical University General Hospital, Tianjin

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

Taizhou Hospital of Zhejiang Province, Linhai

Fujian Cancer Hospital, Fuzhou

Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou

The Second Affiliated Hospital of Army Medical University, People's Liberation Army, Chongqing

Army Special Medical Center of Peoples Liberation Army, Chongqing

Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

Sun Yat-Sen University Cancer Center, Guangzhou

Jiangmen Central Hospital, Jiangmen